Skip to content
10-Q

Quarterly Report

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

0001193125-11-123798

← back to feed
Filed
May 3, 2011 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2011 · Apr 27, 2011 113.24M sh
Shares Diluted Q1 2011 · Mar 31, 2011 118.18M sh
Shares Diluted Q1 2011 · Mar 31, 2010 119.19M sh
Stock Repurchased Q1 2011 · Mar 31, 2011 $200M
Dividends Paid Q1 2011 · Mar 31, 2011 $18.98M
Dividends Paid Q1 2011 · Mar 31, 2010 $17.78M
Capex Q1 2011 · Mar 31, 2011 $22.18M
Capex Q1 2011 · Mar 31, 2010 $11.15M
Operating Cash Flow Q1 2011 · Mar 31, 2011 $41.92M
Operating Cash Flow Q1 2011 · Mar 31, 2010 $62.02M
Cash And Equivalents Q1 2011 · Mar 31, 2011 $349.78M
Cash And Equivalents Q1 2011 · Dec 31, 2010 $479.57M
Cash And Equivalents Q1 2011 · Mar 31, 2010 $480.57M
Cash And Equivalents Q1 2011 · Dec 31, 2009 $408.9M
Stockholders Equity Q1 2011 · Mar 31, 2011 $1.13B
Stockholders Equity Q1 2011 · Dec 31, 2010 $1.28B
Current Liabilities Q1 2011 · Mar 31, 2011 $634.39M
Current Liabilities Q1 2011 · Dec 31, 2010 $613.71M
Total Liabilities Q1 2011 · Mar 31, 2011 $722.05M
Total Liabilities Q1 2011 · Dec 31, 2010 $701.38M
Current Assets Q1 2011 · Mar 31, 2011 $963.12M
Current Assets Q1 2011 · Dec 31, 2010 $1.13B
Total Assets Q1 2011 · Mar 31, 2011 $1.86B
Total Assets Q1 2011 · Dec 31, 2010 $1.99B
Eps Diluted Q1 2011 · Mar 31, 2011 $0.32
Eps Diluted Q1 2011 · Mar 31, 2010 $0.14
Eps Basic Q1 2011 · Mar 31, 2011 $0.32
Eps Basic Q1 2011 · Mar 31, 2010 $0.15
Rd Expense Q1 2011 · Mar 31, 2011 $2.22M
Rd Expense Q1 2011 · Mar 31, 2010 $6.34M
Net Income Q1 2011 · Mar 31, 2011 $37.37M
Net Income Q1 2011 · Mar 31, 2010 $17.21M
Operating Income Q1 2011 · Mar 31, 2011 $52.45M
Operating Income Q1 2011 · Mar 31, 2010 $27.68M
Revenue Q1 2011 · Mar 31, 2011 $383.2M
Revenue Q1 2011 · Mar 31, 2010 $346.77M